These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 24497711)

  • 1. Mutational identification of fibroblast growth factor receptor 1 and fibroblast growth factor receptor 2 genes in craniosynostosis in Indian population.
    Pandey RK; Bajpai M; Ali A; Gayan S; Singh A
    Indian J Hum Genet; 2013 Oct; 19(4):449-53. PubMed ID: 24497711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and genetic characteristics of craniosynostosis in Hungary.
    Bessenyei B; Nagy A; Szakszon K; Mokánszki A; Balogh E; Ujfalusi A; Tihanyi M; Novák L; Bognár L; Oláh É
    Am J Med Genet A; 2015 Dec; 167A(12):2985-91. PubMed ID: 26289989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequence analysis of fibroblast growth factor receptor 2 ( FGFR2 ) in Japanese patients with craniosynostosis.
    Sakai N; Tokunaga K; Yamazaki Y; Shida H; Sakata Y; Susami T; Nakakita N; Takato T; Uchinuma E
    J Craniofac Surg; 2001 Nov; 12(6):580-5. PubMed ID: 11711827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Description of a new mutation and characterization of FGFR1, FGFR2, and FGFR3 mutations among Brazilian patients with syndromic craniosynostoses.
    Passos-Bueno MR; Sertié AL; Richieri-Costa A; Alonso LG; Zatz M; Alonso N; Brunoni D; Ribeiro SF
    Am J Med Genet; 1998 Jul; 78(3):237-41. PubMed ID: 9677057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Negative autoregulation of fibroblast growth factor receptor 2 expression characterizing cranial development in cases of Apert (P253R mutation) and Pfeiffer (C278F mutation) syndromes and suggesting a basis for differences in their cranial phenotypes.
    Britto JA; Moore RL; Evans RD; Hayward RD; Jones BM
    J Neurosurg; 2001 Oct; 95(4):660-73. PubMed ID: 11596961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast Growth Factor Receptor 2 (
    Azoury SC; Reddy S; Shukla V; Deng CX
    Int J Biol Sci; 2017; 13(12):1479-1488. PubMed ID: 29230096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical study and some molecular features of Mexican patients with syndromic craniosynostosis.
    Ibarra-Arce A; Almaraz-Salinas M; Martínez-Rosas V; Ortiz de Zárate-Alarcón G; Flores-Peña L; Romero-Valdovinos M; Olivo-Díaz A
    Mol Genet Genomic Med; 2020 Aug; 8(8):e1266. PubMed ID: 32510873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Mechanisms Involved in Craniosynostosis.
    Yapijakis C; Pachis N; Sotiriadou T; Vaila C; Michopoulou V; Vassiliou S
    In Vivo; 2023; 37(1):36-46. PubMed ID: 36593018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicogenetic study of Turkish patients with syndromic craniosynostosis and literature review.
    Nur BG; Pehlivanoğlu S; Mıhçı E; Calışkan M; Demir D; Alper OM; Kayserili H; Lüleci G
    Pediatr Neurol; 2014 May; 50(5):482-90. PubMed ID: 24656465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel mutation detection of fibroblast growth factor receptor 1 (FGFR1) gene, FGFR2IIIa, FGFR2IIIb, FGFR2IIIc, FGFR3, FGFR4 gene for craniosynostosis: A prospective study in Asian Indian patient.
    Barik M; Bajpai M; Malhotra A; Samantaray JC; Dwivedi S; Das S
    J Pediatr Neurosci; 2015; 10(3):207-13. PubMed ID: 26557159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dura in the pathogenesis of syndromic craniosynostosis: fibroblast growth factor receptor 2 mutations in dural cells promote osteogenic proliferation and differentiation of osteoblasts.
    Ang BU; Spivak RM; Nah HD; Kirschner RE
    J Craniofac Surg; 2010 Mar; 21(2):462-7. PubMed ID: 20489451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional characterization of a novel FGFR2 mutation, E731K, in craniosynostosis.
    Park J; Park OJ; Yoon WJ; Kim HJ; Choi KY; Cho TJ; Ryoo HM
    J Cell Biochem; 2012 Feb; 113(2):457-64. PubMed ID: 21928350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel mutation, Ala315Ser, in FGFR2: a gene-environment interaction leading to craniosynostosis?
    Johnson D; Wall SA; Mann S; Wilkie AO
    Eur J Hum Genet; 2000 Aug; 8(8):571-7. PubMed ID: 10951518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Syndromic craniosynostosis: from history to hydrogen bonds.
    Cunningham ML; Seto ML; Ratisoontorn C; Heike CL; Hing AV
    Orthod Craniofac Res; 2007 May; 10(2):67-81. PubMed ID: 17552943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FGFR-associated craniosynostosis syndromes and gastrointestinal defects.
    Hibberd CE; Bowdin S; Arudchelvan Y; Forrest CR; Brakora KA; Marcucio RS; Gong SG
    Am J Med Genet A; 2016 Dec; 170(12):3215-3221. PubMed ID: 27481450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotype and clinical care correlations in craniosynostosis: findings from a cohort of 630 Australian and New Zealand patients.
    Roscioli T; Elakis G; Cox TC; Moon DJ; Venselaar H; Turner AM; Le T; Hackett E; Haan E; Colley A; Mowat D; Worgan L; Kirk EP; Sachdev R; Thompson E; Gabbett M; McGaughran J; Gibson K; Gattas M; Freckmann ML; Dixon J; Hoefsloot L; Field M; Hackett A; Kamien B; Edwards M; Adès LC; Collins FA; Wilson MJ; Savarirayan R; Tan TY; Amor DJ; McGillivray G; White SM; Glass IA; David DJ; Anderson PJ; Gianoutsos M; Buckley MF
    Am J Med Genet C Semin Med Genet; 2013 Nov; 163C(4):259-70. PubMed ID: 24127277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Syndromic craniosynostosis, fibroblast growth factor receptor 2 (FGFR2) mutations, and sacrococcygeal eversion presenting as human tails.
    Wilkinson CC; Manchester DK; Keating RF; Ketch LL; Winston KR
    Childs Nerv Syst; 2012 Aug; 28(8):1221-6. PubMed ID: 22661218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-Wide Association Study in Craniosynostosis Condition Using Innovative Systematic Bioinformatic Analysis Tools and Techniques: Future Prospective and Clinical Practice.
    Barik M; Bajpai M; Malhotra A; Samantaray JC; Dwivedi S; Das S
    J Pediatr Neurosci; 2018; 13(2):170-175. PubMed ID: 30090130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [From gene to disease; craniosynostosis syndromes due to FGFR2-mutation].
    van Ravenswaaij-Arts CM; van den Ouweland AM; Hoogeboom AJ; Herbergs J; Pals G
    Ned Tijdschr Geneeskd; 2002 Jan; 146(2):63-6. PubMed ID: 11820058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S267P mutation in FGFR2: first report in a patient with Crouzon syndrome.
    Ke R; Yang X; Ge M; Cai T; Lei J; Mu X
    J Craniofac Surg; 2015 Mar; 26(2):592-4. PubMed ID: 25759927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.